The role of copper in neurodegenerative disease

Neurobiology of Disease

Volumn 6, Issue 4, 1999, Pages 221-230

  Waggoner, Darrel J ^a   Bartnikas, Thomas B ^a   Gitlin, Jonathan D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aceruloplasminemia; Alzheimer's disease; Amyotrophic lateral sclerosis; Copper; Menkes disease; Prion disease; Wilson disease

Indexed keywords

ALPHA AMIDATING ENZYME; CERULOPLASMIN; COPPER; CYTOCHROME C OXIDASE; DOPAMINE BETA MONOOXYGENASE; MONOPHENOL MONOOXYGENASE; PROTEIN LYSINE 6 OXIDASE; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; COPPER METABOLISM; DEGENERATIVE DISEASE; ENZYME ACTIVITY; HUMAN; MENKES SYNDROME; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PRION DISEASE; PRIORITY JOURNAL; REVIEW; WILSON DISEASE;

EID: 0032887626     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1999.0250     Document Type: Review

References (98)

1. Akil M., Schwartz J. A., Dutchak D., Yuzbasiyan-Gurkan V., Brewer G. J. The psychiatric presentations of Wilson's disease. J. Neuropsychol. Clin. Neurosci. 3:1991;377-382.
2. Askwith C., Eide D., VanHo A., Bernard P. S., Li L., Davis-Kaplan S., Sipe D. M., Kaplan J. The FET3 gene of S. Cerevisiae encodes a multicopper oxidase required for ferrous iron uptake. Cell. 76:1994;403-410.
3. Atwood C. S., Moir R. D., Huang X., Scarpa R. C., Bacarra N. M. E., Romano D. M., Hartshorn M. A., Tanzi R. E., Bush A. I. Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem. 273:1998;12817-12826.
4. Beckman J. S., Carson M., Smith C. D., Koppenol W. H. ALS, SOD and peroxynitrite. Nature. 364:1993;584.
5. Borchelt D. R., Lee M. K., Slunt H. S., Guarnieri M., Xu Z.-S., Wong P. C., Brown R. H. Jr., Price D. L., Sisodia S. S., Cleveland D. W. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Natl. Acad. Sci. 91:1994;8292-8296.
6. Borchelt D. R., Guarnieri M., Wong P. C., Lee M. K., Slunt H. A., Xu Z.-S., Sisodia S. S., Price D. L., Cleveland D. W. Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function. J. Biol. Chem. 270:1995;3234-3238.
7. Borjigin J., Payne A. S., Deng J., Li X., Wang M. M., Ovodenko B., Gitlin J. D., Snyder S. H. A novel pineal night-specific ATPase encoded by the Wilson disease gene. J. Neurosci. 19:1999;1018-1026.
8. Brown D. R., Qin K., Herms J. W., Madlung A., Manson J., Strome R., Fraser P. E., Kruck T., vonBohlen A., Schulz-Schaeffer W., Giese A., Westerway D., Kretzschmar H. The cellular prion protein binds copper in vivo. Nature. 390:1997;684-687.
9. Brown D. R., Besinger A. Prion protein expression and superoxide dismutase activity. Biochem. J. 334:1998;423-429.
10. Bruijn L. I., Beal M. F., Becher M. W., Schulz J. B., Wong P. C., Price D. L., Cleveland D. W. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. Proc. Natl. Acad. Sci. USA. 94:1997;7606-7611.
11. Bruijn L. I., Houseweart M. K., Kato S., Anderson K. L., Anderson S. D., Ohama E., Reaume A. G., Scott R. W., Cleveland D. W. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science. 281:1998;1851-1854.
12. Büeler H. A., Fischer M., Lang Y., Bluethmann H., Lipp H. P., DeArmond S. J., Prusiner S. B., Aguet M., Weissmann C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature. 356:1992;577-582.
13. Bull P. C., Thomas G. R., Rommens J. M., Forbes J. R., Cox D. W. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat. Genet. 5:1993;327-337.
14. Casareno R. L. B., Waggoner D., Gitlin J. D. The copper chaperone CCS directly interacts with copper/zinc superoxide dismutase. J. Biol. Chem. 273:1998;23625-23628.
15. Chelly J., Tumer Z., Tonnesen T., Petterson A., Ishikawa-Brush Y., Tommerup N., Horn N., Monaco A. P. Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nat. Genet. 3:1993;14-19.
16. Corson L. B., Strain J. J., Culotta V. C., Cleveland D. W. Chaperone-facilitated copper binding is a property common to several classes of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants. Proc. Natl. Acad. Sci. USA. 95:1998;6301-6366.
17. Crow J. P., Sampson J. B., Zhuang Y., Beckman J. S. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J. Neurochem. 69:1997;1936-1944.
18. Cudkowicz M. E., McKenna-Yasek D., Sapp P. E., Chin W., Geller B., Hayden D. L., Schoenfeld D. A., Hosler B. A., Horvitz H. R., Brown R. H. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann. Neurol. 41:1997;210-221.
19. Culotta V. C., Gitlin J. D. Disorders of copper transport. Scriver C. R., Beaudet A. L., Sly W. S., Valle D. The Molecular and Metabolic Basis of Inherited Disease. 1999;McGraw-Hill.
20. Culotta V. C., Klomp L. W. J., Strain J., Casareno L. B., Krems B., Gitlin J. D. The copper chaperone for superoxide dismutase. J. Biol. Chem. 272:1997;23469-23472.
21. Daimon M., Kato T., Kawanami T., Tominaga M., Igarashi M., Yamatani K., Sasaki H. A nonsense mutation of the ceruloplasmin deficiency with diabetes mellitus. Biochem. Biophys. Res. Commun. 217:1995;89-95.
22. Deng H. X., Hentati A., Tainer J. A., Iqbal Z., Cayabyab A., Hung W. Y., Getzoff E. D., Hu P., Herzfeldt B., Roos R. P. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science. 261:1993;1047-1051.
23. Dening T. R., Berrios G. E. Wilson's disease: Psychiatric symptoms in 195 cases. Arch. Gen. Psychiatry. 46:1989;1126-1134.
24. Dexter D. T., Jenner P. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative disease affecting the basal ganglia. Ann. Neurol. 32:1992;S94-S100.
25. DiDonato M., Narindrasorasak S., Forbes J. R., Cox D. W., Sarkar B. Expression, purification, and metal binding properties of the N-terminal domain from the Wilson disease putative copper-transporting ATPase (ATP7B). J. Biol. Chem. 272:1997;33279-33282.
26. Ferrante R. J., Browne S. E., Shinobu L. A., Bowling A. C., Baik M. J., MacGarvey U., Kowall N. W., Brown R. H. Jr., Beal M. F. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem. 69:1997;2064-2074.
27. Fridovich I. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 64:1995;97-112.
28. Geller T. J., Pan Y., Martin D. S. Early neuroradiologic evidence of degeneration in Menkes disease. Pediatr. Neurol. 17:1997;255-258.
29. Gurney M. E., Pu H., Chiu A. Y., Dal Canto M. C., Polchow C. Y., Alexander D. D., Caliendo J., Hentati A., Kwon Y. W., Deng H.-X., Chen W., Zhai P., Sufit R. L., Siddique T. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 264:1994;1772-1775.
30. Harris Z. L., Takahashi Y., Miyajima H., Serizawa M., MacGillivray R. T. A., Gitlin J. D. Aceruloplasminemia: Molecular characterization of this disorder of iron metabolism. Proc. Natl. Acad. Sci. USA. 92:1995a;2539-2543.
31. Harris Z. L., Migas M. D., Hughes A. E., Logan J. I., Gitlin J. D. Familial dementia due to a frameshift mutation in the caeruloplasmin gene. Q. J. Med. 89:1995b;355-359.
32. Harris Z. L., Gitlin J. D. Genetic and molecular basis for copper toxicity. Am. J. Clin. Nutr. 63:1996;836S-841S.
33. Harris Z. L., Klomp L. W., Gitlin J. D. Aceruloplasminemia: An inherited neurodegenerative disease with impaired iron homeostasis. Am. J. Clin. Nutr. 67:1998;972S-977S.
34. Hesse L., Beher D., Masters C. L., Multhaup G. The βA4 amyloid precursor protein binding to copper. FEBS Lett. 349:1994;109-116.
35. Ho Y. S., Gargano M., Cao J., Bronson R. T., Heimler I., Hutz R. J. Reduced fertility in female mice lacking copper-zinc superoxide dismutase. J. Biol. Chem. 273:1998;7765-7769.
36. Hornshaw M. P., McDermott J. R., Candy J. M. Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. Biochem. Biophys. Res. Commun. 207:1995;621-629.
37. Hottinger A. F., Fine E. G., Gurney M. E., Zurn A. D., Aebischer P. The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis. Eur. J. Neurosci. 9:1997;1548-1551.
38. Hung I. H., Suzuki M., Yamaguchi Y., Yuan D. S., Klausner R. D., Gitlin J. D. Biochemical characterization of the Wilson disease protein and functional expression in the yeast Saccharomyces cerevisiae. J. Biol. Chem. 272:1997;21461-21466.
39. Kimberlin R. H. A comparison of the biochemical changes induced in mouse brain cuprizone toxicity and by scrapie infection. J. Comp. Pathol. 84:1974;263-270.
40. Klomp L. W. J., Farhangrazi Z. S., Dugan L. L., Gitlin J. D. Ceruloplasmin gene expression in the murine central nervous system. J. Clin. Invest. 98:1996a;207-215.
41. Klomp L. W. J., Gitlin J. D. Expression of the ceruloplasmin gene in the human retina and brain: Implications for a pathogenic model in aceruloplasminemia. Hum. Mol. Genet. 5:1996b;1989-1996.
42. LaFontaine S. L., Firth S. D., Camakaris J., Englezou A., Theophilos M. B., Petris M. J., Howie M., Lockhart P. J., Greenough M., Brooks H., Reddel R. R., Mercer J. F. Correction of the copper transport defect of Menkes patient fibroblasts by expression of the Menkes and Wilson ATPases. J. Biol. Chem. 273:1998;31375-31380.
43. Leventer R. J., Kornberg A. J., Phelan E. M., Kean M. J. Early magnetic resonance imaging findings in Menkes disease. J. Child. Neurol. 12:1997;222-224.
44. Liu R., Althaus J. S., Ellerbrock B. R., Becker D. A., Gurney M. E. Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann. Neurol. 44:1998;763-770.
45. Logan J. I., Harveyson K. B., Wisdom G. B., Hughes A. E., Archbold G. P. R. Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus. Q. J. Med. 87:1994;663-670.
46. Lutsenko S., Petrukhin K., Cooper M. J., Gilliam C. T., Kaplan J. H. N-terminal domains of human copper-transporting adenosine triphosphatases (the Wilson's and Menkes disease proteins) bind copper selectively in vivo and in vitro with stoichiometry of one copper per metal-binding repeat. J. Biol. Chem. 272:1997;18939-18944.
47. Lyons T. J., Liu H., Goto J. J., Nersissian A., Roe J. A., Graden J. A., Café C., Ellerby L. M., Bredesen D. E., Gralla E. B., Valentine J. S. Mutations in copper-zinc superoxide dismutase that cause amyotrophic lateral sclerosis alter the zinc binding site and the redox behavior of the protein. Proc. Natl. Acad. Sci. USA. 96:1996;12240-12244.
48. Matzuk M. M., Dionne L., Guo Q., Kumar T. R., Lebovitz R. M. Ovarian function in superoxide dismutase 1 and 2 knockout mice. Endocrinology. 139:1998;4008-4011.
49. McKenzie D., Bartz J., Mirwald J., Olander D., Marsh R., Aiken J. Reversibility of scrapie inactivation is enhanced by copper. J. Biol. Chem. 273:1998;25545-25547.
50. Menkes J. H. Disorders of copper metabolism. Rosenberg R. N., Prosiner S. B., DiMauro S., Barchi R. L. The Molecular and Genetic Basis of Neurological Disease. 1997;1273-1290 Butterworth-Heinemann, Boston.
51. Mercer J. F., Livingston J., Hall B., Paynter J. A., Begy C., Chandrasekharappa S., Lockhart P., Grimes A., Bhave M., Siemieniak D. Isolation of a partial candidate gene for Menkes disease by positional cloning. Nat. Genet. 3:1993;20-25.
52. Miura T., Hori I-A., Takeuchi H. Metal-dependent α-helix formation promoted by the glycine-rich octapeptide region of prion protein. FEBS Lett. 396:1996;248-252.
53. Miyajima H., Nishimura Y., Mizoguchi K., Sakamoto M., Shimizu T., Honda N. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology. 37:1987;761-767.
54. Miyajima H., Takahashi Y., Serizawa M., Kaneko E., Gitlin J. D. Increased plasma lipid peroxidation in patients with aceruloplasminemia. Free Rad. Biol. Med. 20:1996;757-760.
55. Miyajima H., Adachi J., Tatsuno Y., Takahashi Y., Fujimoto M., Kaneko E., Gitlin J. D. Increased very long-chain fatty acids in erythrocyte membranes of patients with aceruloplasminemia. Neurology. 50:1998;130-136.
56. Morita H., Ikeda S., Yamamoto K., Morita S., Yoshida K., Nomoto S., Kato M., Yanagisawa N. Hereditary ceruloplasmin deficiency with hemosiderosis: A clinicopathological study of a Japanese family. Ann. Neurol. 37:1995;646-656.
57. Multhaup G., Schlicksupp A., Hesse L., Beher D., Ruppert T., Masters C. L., Beyreuther K. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science. 271:1996;1406-1509.
58. Multhaup G., Ruppert T., Schlicksupp A., Hesse L., Bill E., Pipkorn R., Masters C. L., Beyreuther K. Copper-binding amyloid precursor protein undergoes a site-specific fragmentation in the reduction of hydrogen peroxide. Biochemistry. 37:1998;7224-7230.
59. Okamoto N., Wada S., Oga T., Kawabata Y., Baba Y., Habu D., Takeda Z., Wada Y. Hereditary ceruloplasmin deficiency with hemosiderosis. Hum. Genet. 97:1996;755-758.
60. Pasinelli P., Borchelt D. R., Houseweart M. K., Cleveland D. W., Brown R. H. Jr. Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase. Proc. Natl. Acad. Sci. USA. 95:1998;15763-15768.
61. Patel B. N., David S. A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J. Biol. Chem. 272:1997;20185-20190.
62. Pattison I. H., Jebbett J. N. Clinical and histological observations on cuprizone toxicity and scrapie in mice. Res. Vet. Sci. 12:1971;378-380.
63. Pauly P. C., Harris D. A. Copper stimulates endocytosis of the prion protein. J. Biol. Chem. 273:1998;33107-33110.
64. Payne A. S., Gitlin J. D. Functional expression of the Menkes disease protein reveals common biochemical mechanisms among the copper-transporting P-type ATPases. J Biol. Chem. 273:1998;3765-3770.
65. Payne A. S., Kelly E. J., Gitlin J. D. Functional expression of the Wilson disease protein reveals mislocalization and impaired copper-dependent trafficking of the common H1069Q mutation. Proc. Natl. Acad. Sci. USA. 95:1998;10854-10859.
66. Petris M. J., Mercer J. F. B., Culvenor J. G., Lockhart P., Gleeson P. A., Camakaris J. Ligand-regulated transport of the Menkes copper P-type ATPase efflux pump from the Golgi apparatus to the plasma membrane: A novel mechanism of regulated trafficking. EMBO J. 15:1996;6084-6095.
67. Petris M. J., Camakaris J., Greenough M., LaFontaine S., Mercer J. F. B. A C-terminal di-leucine is required for localization of the Menkes protein in the trans-Golgi network. Hum. Mol. Genet. 7:1998;2063-2071.
68. Petrukhin K., Lutsenko S., Chernov L., Ross B. M., Kaplan J. H., Gilliam T. C. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: Genomic organization, alternative splicing, and structure/function predicting. Hum. Mol. Genet. 3:1994;1647-1656.
69. Price D. L., Sisodia S. S. Mutant genes in familial Alzheimer's disease and transgenic mice. Annu. Rev. Neurosci. 21:1998;479-505.
70. Prusiner S. B. Prion diseases and the BSE crisis. Science. 278:1997;245-251.
71. Rabizadeh S., Gralla E. B., Borchelt D. R., Gwinn R., Valentine J. S., Sisodia S., Wong P., Lee M., Hahn H., Bredesen D. E. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: Studies in yeast and neural cells. Proc. Natl. Acad. Sci. USA. 92:1995;3024-3028.
72. Reaume A. G., Elliott J. L., Hoffman E. K., Kowall N. W., Ferrante R. J., Siwek D. F., Wilcox H. M., Flood D. G., Beal M. F., Brown R. H. Jr., Scott R. W., Snider W. D. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 13:1996;43-47.
73. Ripps M. E., Huntley G. W., Hof P. R., Morrison J. H., Gordon J. W. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 92:1995;689-693.
74. Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J. P., Deng H.-X., Rahmani Z., Krizus A., Mckenna-Yasek D., Cayabyab A., Gaston S. M., Berger R., Tanzi R. E., Helperin J. J., Herzfeldt B., Van den Bergh R., Hung W.-Y., Bird T., Deng G., Mulder D. W., Smyth C., Laing N. G., Soriano E., Pericak-Vance M. A., Haines J., Rouleau G. A., Gusella J. S., Horvitz H. R., Brown R. H. Jr. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62.
75. Rothstein J. D., Dykes-Hoberg M., Corson L. B., Becker M., Cleveland D. W., Price D. L., Culotta V. C., Wong P. C. The copper chaperone CCS is abundant in neurons and astrocytes in human and rodent brain. J. Neurochem. 72:1999;422-429.
76. Salzer J. L., Lovejoy L., Linder M. C., Rosen C. Ran-2, a glial lineage marker, is a GPI-anchored form of ceruloplasmin. J. Neurosci. Res. 54:1998;147-157.
77. Sato M., Gitlin J. D. Mechanisms of copper incorporation during the biosynthesis of human ceruloplasmin. J. Biol. Chem. 266:1991;5128-5134.
78. Schaefer M., Gitlin J. D. Genetic disorders of membrane transport IV. Wilson's disease and Menkes disease. Am. J. Physiol. 276:1999;G311-G314.
79. Schaefer M., Hopkins R. G., Failla M. L., Gitlin J. D. Hepatocyte-specific localization, copper-dependent trafficking and developmental expression of the Wilson disease protein in the liver. Am J Physiol. 1999.
80. Selkoe D. J. The cell biology of beta-amyloid protein and prescinillin in Alzheimer's disease. Trends Cell Biol. 8:1998;447-453.
81. Siddique T., Nijhawan D., Hentati A. Molecular genetic basis of familial ALS. Neurology. 47:1996;S27-S35.
82. Stockel J., Safar J., Wallace A. C., Cohen F. E., Prusiner S. B. Prion protein selectively binds copper(II) ions. Biochem. 37:1998;7185-7193.
83. Takahashi Y., Miyajima H., Shirabe S., Nagataki S., Suenaga A., Gitlin J. D. Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease. Hum. Mol. Genet. 5:1996;81-84.
84. Tanzi R. E., Petrukhin K., Chernov I., Pellequer J. L, Wasco W., Ross B., Romano D. M. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat. Genet. 5:1993;344-350.
85. Valentine J. S., Gralla E. B. Delivering copper inside yeast and human cells. Science. 278:1997;817-818.
86. Vulpe C., Levinson B., Whitney S., Packman S., Gitschier J. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat. Genet. 3:1993;7-13.
87. Vulpe C. D., Yien-Ming K., Murphy T. L., Lex C., Askwith C., Libina N., Gitschier J., Anderson G. J. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat. Genet. 21:1999;195-199.
88. Walshe J. M. Wilson's disease presenting with features of hepatic dysfunction: A clinical analysis of eighty-seven patients. Q. J. Med. 70:1989;253-263.
89. Wiedau-Pazos M., Goto J. J., Rabizadeh S., Gralla E B., Roe J. A., Lee M. K., Valentine J. S., Bredesen D. E. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science. 271:1996;515-518.
90. Williamson T. L., Cleveland D. W. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 2:1999;50-56.
91. Wong P. C., Pardo C. A., Borchelt D. R., Lee M. K., Copeland N. G., Jenkins N. A., Sisodia S. S., Cleveland D. W., Price D. L. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 14:1995;1105-1116.
92. Wong P. C., Rothstein J. D., Price D. L. The genetic and molecular mechanisms of motor neuron disease. Curr. Opin. Neurobiol. 8:1998;791-799.
93. Yamaguchi Y., Heiny M. E., Gitlin J. D. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem. Biophys. Res. Commun. 197:1993;271-277.
94. Yazaki M., Yoshida K., Nakamura A., Furihata K., Yonekawa M., Okabe T., Yamashita N., Ohta M., Ikeda S. A novel splicing mutation in the ceruloplasmin gene responsible for hereditary ceruloplasmin deficiency with hemosiderosis. J. Neurol. Sci. 156:1998;30-34.
95. Yuan D. S., Stearman R., Dancis A., Dunn T., Beeler T., Klausner R. D. The Menkes/Wilson disease gene homologue in yeast provides copper to a ceruloplasmin-like oxidase required for iron uptake. Proc. Natl. Acad. Sci. USA. 92:1995;2632-2636.
96. Yuan D. S., Dancis A., Klausner R. D. Restriction of copper export in Saccharomyces cerevisiae to a late Golgi or post-Golgi compartment in the secretory pathway. J. Biol. Chem. 272:1997;25787-25793.
97. m for hydrogen peroxide. Proc. Natl. Acad. Sci. USA. 93:1996;5709-5714.
98. Yoshida K., Furihata K., Takeda S., Nakamura A., Yamamoto K., Hiyamuta S., Ikeda S., Shimizu N., Yanagisawa N. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis humans. Nat. Genet. 9:1995;267-272.